Latest & greatest articles for oxycodone

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on oxycodone or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on oxycodone and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for oxycodone

21. Oxycodone / naloxone (Targinact) - Severe pain which can be adequately managed only with opioid analgesics. Naloxone is added to counteract opioid-induced constipation.

Oxycodone / naloxone (Targinact) - Severe pain which can be adequately managed only with opioid analgesics. Naloxone is added to counteract opioid-induced constipation.

Scottish Medicines Consortium2009

22. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients

The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients 18070045 2008 01 17 2008 07 31 2013 11 21 1368-5031 62 2 2008 Feb International journal of clinical practice Int. J. Clin. Pract. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients. 241-7 Most treatments of acute pain associated with non-malignant chronic pains are not satisfactory. The aim of this study is to evaluate the efficacy and side effects (...) of oxycondone controlled release (Oxy-CR) in managing chronic neck pain with acute pain episodes. Randomised, double-blind, stand controlled study. A total of 116 patients were evenly divided into an oxycodone group (Oxy-CR, 5-10 mg and q12 h/day) and a placebo group (placebo, q12 h/day). Patients were assessed for the frequency of pain flares, visual analgesia score (VAS), quality of life (QOL), quality of sleep (QOS) and adverse effects before the treatment and on days 1, 3, 7, 14, 21 and 28 after

EvidenceUpdates2008

23. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone

Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release (...) oxycodone and OROS hydromorphone Ward A, Bozkaya D, Fleischmann J, Dubois D, Sabatowski R, Caro J J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of the Osmotic controlled-Release Oral

NHS Economic Evaluation Database.2007

24. Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain

Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain Article Text Therapeutics Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain Free Magdy W Attia , MD Statistics from Altmetric.com No Altmetric

Evidence-Based Medicine (Requires free registration)2006

25. Oral oxycodone hydrochloride versus epidural anaesthesia for pain control after radical retropubic prostatectomy

Oral oxycodone hydrochloride versus epidural anaesthesia for pain control after radical retropubic prostatectomy Oral oxycodone hydrochloride versus epidural anaesthesia for pain control after radical retropubic prostatectomy Oral oxycodone hydrochloride versus epidural anaesthesia for pain control after radical retropubic prostatectomy Hohwu L, Akre O, Bergenwald L, Tornblom M, Gustafsson O Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) or oral morphine on demand. The second treatment consisted of infiltration of 0.25% bupivacaine (25 to 40 mL) into the wound perioperatively plus oxycodone hydrochloride (OXY) (2 x 10-mg tablets), paracetamol (4 x 1 tablet) and injected or oral morphine on demand. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised patients undergoing RRP. Setting The setting was a hospital. The economic study was carried out in Sweden. Dates

NHS Economic Evaluation Database.2006

26. Oxycodone (OxyNorm) - Post-operative pain

Oxycodone (OxyNorm) - Post-operative pain Secretariat - Delta House 50 West Nile Street Glasgow G1 2NP Telephone 0141 225 6997 Fax 0141 248 3778 E-mail rosie.murray@nhshealthquality.org Chairman Professor David Webb Scottish Medicines Consortium oxycodone (OxyNorm) injection (No. 266/06) Napp Pharmaceuticals Limited Statement of Advice 7 April 2006 ADVICE: in the absence of a submission from the holder of the marketing authorisation. oxycodone (OxyNorm) injection is not recommended for use

Scottish Medicines Consortium2006